Why the study?
Does percutaneous closure of the LAA using the PLAATO system prevent embolic events in high-risk patients with NV-AF and contraindications to anticoagulation?
Population
20 patients with non-valvular atrial fibrillation, contraindications to anticoagulant therapy, and high risk…
Design
Cohort
Follow-up
mean 40 +/- 10 months
Authors
Loading...
Hypothesis-generating for embolic prevention with PLAATO LAA closure in anticoagulation-ineligible NV-AF; randomized trials needed before adoption.
Does percutaneous closure of the LAA using the PLAATO system prevent embolic events in high-risk patients with NV-AF and contraindications to anticoagulation?
Percutaneous LAA closure using the PLAATO system appears safe and feasible, with no embolic events observed over a mean 40-month follow-up in a small cohort of high-risk NV-AF patients contraindicated for anticoagulation.
Ussia et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: